Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor
- PMID: 3095427
Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor
Abstract
Culture medium conditioned by activated human T lymphocytes enhances the in vitro cytotoxicity of purified human eosinophils toward Schistosoma mansoni larvae, suggesting the existence of a mechanism for T lymphocyte regulation of eosinophil function. Here we show that purified biosynthetic (recombinant) human T lymphocyte granulocyte-macrophage colony-stimulating factor (GM-CSF) enhanced markedly two eosinophil functions: cytotoxicity toward schistosomula by a mean of 676%, and calcium ionophore A23187-induced generation of leukotriene C4 (LTC4) by a mean of 135%. Augmentation of each eosinophil function by GM-CSF was time- and dose-dependent, with a dose-response relationship at concentrations between 1 and 20 pM. Tumor necrosis factor (TNF) enhanced eosinophil cytotoxicity with slower kinetics, a different dose-dependence relationship, and to a lower maximum, as compared with GM-CSF. There was no detectable effect of TNF on calcium ionophore A23187-induced generation of LTC4. The effect of GM-CSF on arachidonic acid metabolism to LTC4 reached a plateau with 60 min of incubation before stimulation with ionophore, and was characterized by an initial augmentation of the intracellular level of LTC4 and a subsequent increment in extracellular LTC4. Thus, GM-CSF can serve as a mediator for T lymphocyte regulation of functions of mature eosinophils. It is also the first defined macromolecule known to enhance metabolism of membrane-derived arachidonic acid via the 5-lipoxygenase pathway.
Similar articles
-
Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis.J Immunol. 1988 Jun 15;140(12):4315-22. J Immunol. 1988. PMID: 2453577
-
Identification of an alveolar macrophage-derived activity in bronchial asthma that enhances leukotriene C4 generation by human eosinophils stimulated by ionophore A23187 as a granulocyte-macrophage colony-stimulating factor.Am Rev Respir Dis. 1989 Nov;140(5):1340-7. doi: 10.1164/ajrccm/140.5.1340. Am Rev Respir Dis. 1989. PMID: 2510565
-
Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.J Exp Med. 1987 Jul 1;166(1):129-41. doi: 10.1084/jem.166.1.129. J Exp Med. 1987. PMID: 3110347 Free PMC article.
-
Cytokine regulation of eosinophil function.Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 2):S55-9. doi: 10.1016/0090-1229(92)90041-l. Clin Immunol Immunopathol. 1992. PMID: 1728988 Review.
-
Eosinophil phenotypes and LTC4 generation in vitro and in hypereosinophilic states.Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:481-8. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1825365 Review. No abstract available.
Cited by
-
The role of arachidonic acid metabolites in local and systemic inflammatory processes.Drugs. 1987;33 Suppl 1:10-7. doi: 10.2165/00003495-198700331-00004. Drugs. 1987. PMID: 3036459
-
Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.J Clin Invest. 1989 Mar;83(3):876-82. doi: 10.1172/JCI113971. J Clin Invest. 1989. PMID: 2646320 Free PMC article.
-
Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs.Br J Pharmacol. 1994 Nov;113(3):749-56. doi: 10.1111/j.1476-5381.1994.tb17057.x. Br J Pharmacol. 1994. PMID: 7858864 Free PMC article.
-
Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia.Clin Exp Immunol. 1991 May;84(2):283-8. doi: 10.1111/j.1365-2249.1991.tb08162.x. Clin Exp Immunol. 1991. PMID: 2025954 Free PMC article.
-
Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.Cancer Immunol Immunother. 1989;29(4):288-92. doi: 10.1007/BF00199217. Cancer Immunol Immunother. 1989. PMID: 2665935 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous